Abstract
1. Although capsaicin analogs might be a potential strategy to manipulate inflammation, the mechanism is still unclear. In this study, the effects and action mechanisms of vanilloid analogs on iNOS and COX-2 expression were investigated in RAW264.7 macrophages. 2. Capsaicin and resiniferatoxin (RTX) can inhibit LPS- and IFN-gamma-mediated NO production, and iNOS protein and mRNA expression with similar IC50 values of around 10 microm. 3. Capsaicin also transcriptionally inhibited LPS- and PMA-induced COX-2 expression and PGE2 production. However, this effect exhibited a higher potency (IC50: 0.2 microm), and RTX failed to elicit such responses at 10 microm. 4. Interestingly, we found that capsazepine, a competitive TRPV1 antagonist, did not prevent the inhibition elicited by capsaicin or RTX. Nevertheless, it mimicked vanilloids in inhibiting iNOS/NO and COX-2/PGE2 induction with an IC50 value of 3 microm. RT-PCR and immunoblotting analysis excluded the expression of TRPV1 in RAW264.7 macrophages. 5. The DNA binding assay demonstrated the abilities of vanilloids to inhibit LPS-elicited NF-kappaB and AP-1 activation and IFN-gamma-elicited STAT1 activation. The reporter assay of AP-1 activity also supported this action. 6. The kinase assay indicated that ERK, JNK, and IKK activation by LPS were inhibited by vanilloids. 7. In conclusion, vanilloids can modulate the expression of inflammatory iNOS and COX-2 genes in macrophages through interference with upstream signalling events of LPS and IFN-gamma. These findings provide new insights into the potential benefits of the active ingredient in hot chilli peppers in inflammatory conditions.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Capsaicin / analogs & derivatives*
-
Capsaicin / pharmacology*
-
Cell Line
-
Cyclooxygenase 2
-
DNA-Binding Proteins / metabolism
-
Dinoprostone / biosynthesis
-
Diterpenes / pharmacology
-
Dose-Response Relationship, Drug
-
Enzyme Activation / drug effects
-
Enzyme Induction / drug effects
-
Ganglia, Spinal / drug effects
-
Ganglia, Spinal / metabolism
-
I-kappa B Kinase
-
Interferon-gamma / pharmacology
-
Isoenzymes / biosynthesis*
-
Isoenzymes / genetics
-
JNK Mitogen-Activated Protein Kinases
-
Lipopolysaccharides / pharmacology
-
Macrophages / drug effects*
-
Macrophages / enzymology
-
Macrophages / metabolism
-
Male
-
Mitogen-Activated Protein Kinases / metabolism
-
NF-kappa B / metabolism
-
Neurotoxins / pharmacology
-
Nitric Oxide Synthase / antagonists & inhibitors*
-
Nitric Oxide Synthase / genetics
-
Nitric Oxide Synthase / metabolism
-
Nitric Oxide Synthase Type II
-
Prostaglandin-Endoperoxide Synthases / biosynthesis*
-
Prostaglandin-Endoperoxide Synthases / genetics
-
Protein Serine-Threonine Kinases / metabolism
-
RNA, Messenger / drug effects
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Drug / genetics
-
Receptors, Drug / metabolism
-
STAT1 Transcription Factor
-
Signal Transduction
-
Tetradecanoylphorbol Acetate / pharmacology
-
Trans-Activators / metabolism
-
Transcription Factor AP-1 / metabolism
Substances
-
DNA-Binding Proteins
-
Diterpenes
-
Isoenzymes
-
Lipopolysaccharides
-
NF-kappa B
-
Neurotoxins
-
RNA, Messenger
-
Receptors, Drug
-
STAT1 Transcription Factor
-
Stat1 protein, rat
-
Trans-Activators
-
Transcription Factor AP-1
-
Interferon-gamma
-
resiniferatoxin
-
Nitric Oxide Synthase
-
Nitric Oxide Synthase Type II
-
Nos2 protein, rat
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
Protein Serine-Threonine Kinases
-
I-kappa B Kinase
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinases
-
Dinoprostone
-
capsazepine
-
Tetradecanoylphorbol Acetate
-
Capsaicin